CLINICAL ROLE -
Trending News Today: FDA Accelerated Pathways Speed Approvals Up to 1 Year
Top news of the day from across the health care landscape.
Read More
Adaptation Causes Invasive Pneumococcal Disease Rates to Grow
Researchers explore the impact of pneumococcal vaccines and antibiotic usage on trends in colonization in young, healthy children.
Technology Advancements in Pharmacy Improve Care
Pharmacy professionals must embrace a number of changes in technology.
5 Steps to Changing Our Mindsets to Achieve Goals
Success is 80% psychology and 20% mechanics. Here is how to speed up the path to success.
A Look at Antibiotics to Treat Pneumonia
This chart provides a simple way to answer questions that pharmacists will receive this winter.
Once-Weekly Semaglutide Approved for Type 2 Diabetes
The FDA issued approval to semaglutide injection (Ozempic) for type 2 diabetes.
FDA Approves Once-Weekly Semaglutide for Type 2 Diabetes
The FDA has approved Novo Nordisk’s semaglutide injection (Ozempic), a glucagon-like peptide 1 (GLP-1) receptor agonist, as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.
Consequences of Exclusivity in the Independent Specialty Pharmacy Market
Independent pharmacies must stay on top of developing trends across the specialty pharmacy landscape.
What You Need to Know About the CVS-Aetna Merger
The CVS-Aetna acquisition could have several implications for pharmacies and patients.
Bacterial Enzyme Responsible for Crohn's Disease Development
Genetically engineering the gut microbiome may hold the key to treating Crohn’s disease.
Cancer Surgery Increases Risk of Opioid Addiction
Patients receiving adjuvant chemotherapy are at a high risk of new persistent opioid use.
Researchers Discover Eczema Subtypes
A newly-discovered eczema subtype may be linked to asthma and allergies.
Trending News Today: Financial Incentives May Increase Utilization of Preventive Services
Top news of the day from across the healthcare landscape.
Trending News Today: Colorado Lifts HCV Drug Limits for Medicaid Patients
FDA Approves Cancer Biomarker Test, CMS Suggests Insurance Coverage Options
Centers for Medicare & Medicaid Services proposed national coverage determination of the FoundationOne CDx test.
Blood-Brain Barrier May Present Treatment Target in Multiple Sclerosis
Targeting specific transportation system across the damaged blood-brain barrier could halt MS disease progression.
Taltz Gets FDA Approval for Psoriatic Arthritis
Ixekizumab found to provide significant improvement in joint symptoms for patients not previously treated with a biologic disease-modifying antirheumatic drug.
Medication Management in Schools: Pharmacist Involvement Can Improve Outcomes
Between 10% and 20% of students in kindergarten through high school have chronic illness.
FDA OKs Evolocumab for Prevention of Cardiovascular Events
The FDA extended the approval of evolocumab (Repatha, Amgen) to include the prophylaxis of heart attacks, strokes, and coronary revascularizations in adults with established heart disease.
Evolocumab Approved to Prevent Heart Attack, Stroke
Evolocumab (Repatha) is the only PCSK9 inhibitor approved to prevent heart attack, stroke, and coronary revascularization.
FDA Notes Progress Implementing 21st Century Cures Act
FDA plans to further expedite novel treatments under the 21st Century Cures Act.
Confirmatory HIV Testing May Reduce Misdiagnosis Among Pediatric Patients
A second HIV test may avoid significant costs.
Investigational ALS Drug Fails in Phase 3 Clinical Trial
Development of tirasemtiv halted due to poor performance in a late-stage clinical trial.
Global Diabetes Rates Continue to Climb
Nearly 700 million individuals around the world will develop diabetes by 2045, many of whom are undiagnosed.
Diabetes Linked to Breast Cancer Risk in African American Women
Women with type 2 diabetes were 43% more likely to develop estrogen receptor negative breast cancer than patients without diabetes.
Trending News Today: CVS-Aetna Merger Could Change Healthcare
Trending News Today: FDA Approves Cancer-Gene Profiling Test
New CDC Guidelines Target Hepatitis B
Screening for HBV among high-risk populations is crucial to stopping transmission of the virus.
Cosentyx Shows Promise Treating Nail, Palmoplantar Psoriasis
Patients with moderate-to-severe nail psoriasis treated with secukinumab experienced significant improvement in the Nail Psoriasis Severity Index.
Trelegy Ellipta for COPD: What Pharmacists Should Know
The medication is indicated for the long-term, once-daily maintenance treatment of patients with chronic obstructive pulmonary disease.
